SPARC

Historical price data

SPARC is a specialized research and development arm that emerged from Sun Pharmaceutical Industries, concentrating on innovative drug delivery technologies and new molecular entities. The company has built a pipeline of novel formulations and new chemical entities targeting complex therapeutic areas with high unmet medical needs. Its strategic focus includes developing non-infringing, patent-protected products that offer significant clinical advantages over existing treatments. SPARC's valuation reflects its potential to deliver breakthrough innovations through its research platforms.

Proprietary novel drug delivery systems (NDDS) focusing on ophthalmic, neurological, and dermatological applications, including sustained-release formulations and nanotechnology-based delivery platforms.

SPARC competes with large pharmaceutical companies like Novartis and AbbVie in ophthalmology, as well as specialty pharma and generic manufacturers. Its differentiation lies in novel drug delivery systems rather than new molecular entities, potentially reducing development risk while creating patent-protected products with clinical advantages.